Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
crizotinib (xalkori) (1 trial)
hcp1902 (1 trial)
hgp2001 (1 trial)
hip2001 (1 trial)
nvp-2002 (1 trial)
rld2007 (1 trial)
rld2008 (1 trial)
testosterone (delatestryl) (1 trial)
Hypogonadism (Phase 1)
Trials (5 total)
Trial APIs (8 total)